Print-ready dossier — use your browser's print dialog to save as PDF.
25 EasyMax FTS Set EN-ES
Model EASY MAX · EPS BIO TECHNOLOGY CORP. · DI 00885017000270
NBW — System, Test, Blood Glucose, Over The Counter · Class II · 21 CFR 862.1345
UDILibrary device dossier · generated 2026-09-14 · sources: FDA GUDID, openFDA (recalls, MAUDE, 510(k)/PMA), FDA Data Dashboard (inspections, compliance actions), 510(k) summary documents.
Recall history (0)
No recalls linked in the loaded window.
Adverse-event reports — MAUDE (0)
Caveat (required reading): MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line is a reporting baseline (average device in the same product code), not a risk measure.
Monthly adverse-event reports for this device versus the product-code average.
Month
This device (reports)
Product-code average (reports per device)
2019-01
0
14.01
2019-02
0
19.34
2019-03
0
21.77
2019-04
0
28.26
2019-05
0
26.14
2019-06
0
24.19
2019-07
0
24.82
2019-08
0
22.58
2019-09
0
20.42
2019-10
0
22.67
2019-11
0
16.37
2019-12
0
19.89
2020-01
0
22.19
2020-02
0
18.44
2020-03
0
20.57
2020-04
0
17.63
2020-05
0
24.77
2020-06
0
30.27
2020-07
0
18.51
2020-08
0
12.33
2020-09
0
19.58
2020-10
0
12.45
2020-11
0
18.13
2020-12
0
18.98
2021-01
0
16.35
2021-02
0
17.07
2021-03
0
18.21
2021-04
0
19.62
2021-05
0
20
2021-06
0
19.7
2021-07
0
28.06
2021-08
0
17.13
2021-09
0
21.17
2021-10
0
19.14
2021-11
0
16.63
2021-12
0
23.6
2022-01
0
16.23
2022-02
0
15.33
2022-03
0
17.98
2022-04
0
16.62
2022-05
0
18.6
2022-06
0
14.8
2022-07
0
14.55
2022-08
0
8
2022-09
0
9.32
2022-10
0
8.08
2022-11
0
11.65
2022-12
0
7.24
2023-01
0
13.11
2023-02
0
9.6
2023-03
0
9.9
2023-04
0
7.78
2023-05
0
36.62
2023-06
0
23.03
2023-07
0
13.17
2023-08
0
11.24
2023-09
0
6.48
2023-10
0
6.48
2023-11
0
4.73
2023-12
0
4.39
2024-01
0
8.58
2024-02
0
2.73
2024-03
0
7.97
2024-04
0
4.02
2024-05
0
7.3
2024-06
0
5.13
2024-07
0
3.64
2024-08
0
3.3
2024-09
0
3.83
2024-10
0
4.44
2024-11
0
2.81
2024-12
0
5.57
2025-01
0
5.49
2025-02
0
2.66
2025-03
0
2.86
2025-04
0
3.69
2025-05
0
4.88
2025-06
0
3.09
2025-07
0
3.13
2025-08
0
4.73
2025-09
0
2.75
2025-10
0
3.59
2025-11
0
3.6
2025-12
0
2.64
2026-01
0
4.2
2026-02
0
2.35
2026-03
0
3.51
2026-04
0
3.03
2026-05
0
3.02
2026-06
0
4.17
This device (reports/month)Average device in NBW (reports/device/month)
Regulatory clearances
None linked in the loaded window.
Manufacturer compliance record — EPS BIO TECHNOLOGY CORP.
Warning Letter 2012-09-12 EPS Bio Technology Corp.
Warning Letter 2012-09-12 EPS Bio Technology Corp.
VAI 2026-01-15 EPS Bio Technology Corp. · 3 citations
VAI 2026-01-15 EPS Bio Technology Corp. · 3 citations
VAI 2023-10-26 EPS Bio Technology Corp. · 0 citations
VAI 2023-10-26 EPS Bio Technology Corp. · 0 citations
VAI 2020-01-08 EPS Bio Technology Corp. · 0 citations
VAI 2020-01-08 EPS Bio Technology Corp. · 0 citations
VAI 2013-07-26 EPS Bio Technology Corp. · 0 citations
VAI 2013-07-26 EPS Bio Technology Corp. · 0 citations
OAI 2012-06-21 EPS Bio Technology Corp. · 0 citations
OAI 2012-06-21 EPS Bio Technology Corp. · 0 citations